Category : Search result: pharmaceutical cannabis


Spain Legalises Medical Cannabis Under Strict Rules

Spain joins European nations embracing medical cannabis as parliament approves landmark legislation for chronic pain, multiple sclerosis and chemotherapy side effects, with tight government controls.

NHS medical cannabis crisis leaves thousands untreated

Exclusive investigation reveals how chronic pain and menopause patients are being forced into private healthcare or illegal markets as NHS medical cannabis prescriptions remain virtually inaccessible five years after legalisation.

Big Pharma's Legal War Threatens NHS Drug Access

Pharmaceutical giants are launching an unprecedented legal assault against the UK government, threatening NHS access to vital medicines and putting patient care at risk in a battle over drug pricing.

British teen faces 15 years in Bali prison over drugs

Nelson James, a 19-year-old from Essex, confronts devastating drug charges in Bali after police discover cannabis and magic mushrooms in his villa. The shocking case serves as a stark warning to British travellers about Indonesia's severe narcotics laws.

Trump's CBD Backing Sends UK Cannabis Stocks Soaring

Former President Donald Trump's endorsement of CBD sparks unprecedented surge in UK-listed cannabis companies, while landmark US Medicaid decision opens doors for medical cannabis coverage. Explore the market implications and what this means for British i

Chinese Executive Jailed in US Fentanyl Case

A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.

NHS Drug Pricing: The Art of the Deal Saving Millions

Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.

New Weight Loss Pill Cuts Body Weight By 20%

Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.

Murder charges after pensioner dies in house fire

A woman and a man have been remanded in custody, charged with the murder of a pensioner who died in a deliberately set house fire, alongside serious drug offences, in a shocking case that has rocked a local community.

Big Pharma's Billion-Pound Bet on Post-Trump UK

Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.

AstraZeneca Pauses £500m Cambridge HQ Investment

Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.

Common Meds Linked to Youth Suicide Surge, Study Finds

Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg

Cannabis farmer caught after dropping trail of leaves

A bungling cannabis cultivator in West Yorkshire was caught after accidentally scattering a trail of marijuana leaves from his car directly to his illicit farm, leading police on a comically easy investigation.

MSD to create 125+ new R&D jobs in London expansion

Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader

Mounjaro KwikPens launch without price reduction

Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.

Page 1 of 4